Invention Grant
- Patent Title: MiR-204 and miR-211 and uses thereof
-
Application No.: US14774586Application Date: 2014-03-11
-
Publication No.: US10369231B2Publication Date: 2019-08-06
- Inventor: Sandro Banfi , Enrico Maria Surace , Ivan Conte , Marianthi Karali , Elena Marrocco
- Applicant: FONDAZIONE TELETHON
- Applicant Address: IT Rome
- Assignee: FONDAZIONE TELETHON
- Current Assignee: FONDAZIONE TELETHON
- Current Assignee Address: IT Rome
- Agency: Lucas & Mercanti, LLP
- Priority: EP13158603 20130311
- International Application: PCT/EP2014/054755 WO 20140311
- International Announcement: WO2014/140051 WO 20140918
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/11 ; C12N15/86 ; C12N15/113 ; A61K31/7105
Abstract:
The present invention relates to at least one agent capable of increasing the level of one or more miRNA in a cell or cells of a subject, said miRNA comprising the sequence UUCCCUU, for use in the treatment and/or prevention of a retinal dystrophy, in particular characterized by photoreceptor degeneration, relative pharmaceutical compositions, nucleic acids, vectors and host cells.
Public/Granted literature
- US20160022836A1 miR-204 and miR-211 and uses thereof Public/Granted day:2016-01-28
Information query
